v3.25.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Shares

The following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they would be anti-dilutive:

 

         
   June 30, 
   2025   2024 
Common stock warrants August 2021   14,031    14,031 
Underwriter warrants August 2021   284    284 
Chanticleer warrants   6    6 
Series C warrants   2,297    2,297 
Series 3 warrants   1,566    1,566 
Unvested restricted stock units and awards       17,152 
Common stock warrants February 2023   31,563    33,982 
Underwriter warrants February 2023   1,933    1,933 
Common stock private placement warrants June 2023   28,409    28,409 
Placement agent warrants June 2023   852    852 
Common stock warrants October 2023   354,994    354,994 
Underwriter warrants October 2023   10,664    10,664 
Placement agent warrants June 2024   14,142    14,142 
Common stock warrants June 2024   703,125    703,125 
Common stock warrants November 2024   2,222,222     
Common stock registered direct warrants December 2024   1,085,325     
Common stock PIPE warrants December 2024   673,000     
Total anti-dilutive weighted average shares    5,144,413    1,183,437